Abstract
Marine natural products that feature polycyclic guanidine motifs, such as crambescidins and batzelladines, are known to have antiviral activities toward some viruses including HSV and HIV. In this study we evaluated a synthetic library containing 28 batzelladine analogues, the structures of which encompass and surpass variations seen in natural batzelladines, for their ability to inhibit HIV-1 envelope-mediated cell-cell fusion. Clear structure-activity relationships were revealed and indicated that the best inhibitors of fusion were most similar in structure to natural batzelladine F, with IC50 values ranging from 0.8 to 3.0 microM. Proceeding from the earlier finding that some batzelladines block gp120-CD4 binding, modeling studies of inhibitors binding to the CD4 binding site on gp120 were carried out. The lowest energy models suggest a preferred orientation for inhibitor binding that is consistent with the observed structure-activity relationships.
References
Sep 1, 1994·Journal of Virology·O NussbaumE A Berger
Jun 26, 1998·Nature·P D KwongW A Hendrickson
Oct 9, 1999·Journal of Medicinal Chemistry·P R CarlierY P Pang
Aug 10, 2000·Angewandte Chemie·P R CarlierY P Pang
Feb 24, 2001·Structure·P D KwongW A Hendrickson
Sep 25, 2001·Journal of Magnetic Resonance·C D Schwieters, G M Clore
Feb 14, 2002·Organic Letters·Kazuo NagasawaYuichi Hashimoto
Feb 5, 2003·Journal of Magnetic Resonance·Charles D SchwietersG Marius Clore
Nov 7, 2003·Organic Letters·Frederick CohenLarry E Overman
Jan 1, 1997·Methods in Enzymology·B C Finzel
Citations
Feb 24, 2006·Journal of the American Chemical Society·Frederick Cohen, Larry E Overman
Dec 29, 2012·Chemical Research in Toxicology·Víctor MartínLuís M Botana
Jul 28, 2005·Natural Product Reports·Roberto G S Berlinck, Miriam H Kossuga
Feb 3, 2006·Natural Product Reports·Gillian M Nicholas, Andrew J Phillips
Sep 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Allison OlszewskiGregory A Weiss
Nov 23, 2013·Expert Opinion on Drug Discovery·Muhammad Khawar RaufAmin Badshah
Mar 29, 2013·Chemical Biology & Drug Design·Nafees AhmedKamlesh K Bhutani
Apr 14, 2016·Marine Drugs·Estelle SfecciMohamed Mehiri
Jul 6, 2005·Virology·Qian ZhaoAsim Kumar Debnath
Jul 16, 2016·Journal of Natural Products·Amr El-DemerdashAli Al-Mourabit
Apr 14, 2017·Bioorganic & Medicinal Chemistry·Yunlong ShiJoshua G Pierce
Jul 5, 2017·Chemical Society Reviews·Magnus W P Bebbington
Jan 6, 2018·Nutrients·Amr El-DemerdashAli Al-Mourabit
Apr 20, 2007·Chemical Biology & Drug Design·Shailza SinghD K Sharma
Sep 15, 2005·Chemistry : a European Journal·Jun ShimokawaKazuo Nagasawa
Mar 21, 2012·Angewandte Chemie·Nicholas R Babij, John P Wolfe
Jul 5, 2013·Angewandte Chemie·Nicholas R Babij, John P Wolfe
Apr 4, 2021·Biomolecules·Amr El-DemerdashJames D Stockand
Jun 1, 2018·Tetrahedron·Christos EconomouSeth B Herzon
Apr 30, 2015·Journal of Natural Products·Mario F C SantosRoberto G S Berlinck